Regeneron Pharmaceuticals, Inc. is expected to report earnings.
REGN Earnings Date
2025-04-29
Fiscal Quarter Ending
Mar/2025
Consensus EPS Forecast
$6.61
EPS of Last Year
N/A
Report Date of Last Year
N/A
MarketCap
$56,982,030,007
Number of Analysts
6